CAR-T Supply and Delivery Process
Average Vein-to-Vein Time(from leukapheresis to infusion)
On-Time Delivery Rate
Temperature Compliance Rate During Transportation
Manufacturing Success Rate
* Since its listing
- APH (Apheresis): Refers to the starting material of patient cells obtained through an apheresis procedure.
- COI (Chain of Identity): A system used to ensure the link in identity and traceability between a patient and their corresponding cell product throughout the processes of collection, manufacturing, transport, and administration.
- DTP (Direct to Patient): A specialized pharmacy service model that involves the sale, delivery, and associated pharmaceutical services for prescription medications directly to patients.
End-to-end in-house management from leukapheresis collection to patient infusion, ensuring full control over critical processes.
The Chain of Identity (COI) system spans the entire workflow, enabling real-time data capture and full-process traceability.
Highly coordinated operations and refined process management help shorten turnaround time and ensure timely product delivery.
Manufactured in compliance with cGMP standards and supported by rigorous quality control to ensure product safety, quality, and consistency.
A patient-centered service model designed to provide a seamless and high-quality treatment experience.